Zacks: Analysts Anticipate Quintiles Transitional Holdings Inc. (Q) Will Post Quarterly Sales of $2.02 Billion

Brokerages expect Quintiles Transitional Holdings Inc. (NYSE:Q) to announce sales of $2.02 billion for the current quarter, according to Zacks Investment Research. Nine analysts have made estimates for Quintiles Transitional Holdings’ earnings, with the lowest sales estimate coming in at $2.00 billion and the highest estimate coming in at $2.03 billion. Quintiles Transitional Holdings posted sales of $1.14 billion in the same quarter last year, which would indicate a positive year over year growth rate of 77.2%. The company is scheduled to issue its next quarterly earnings results on Wednesday, November 1st.

According to Zacks, analysts expect that Quintiles Transitional Holdings will report full-year sales of $2.02 billion for the current fiscal year, with estimates ranging from $8.00 billion to $8.09 billion. For the next financial year, analysts forecast that the business will report sales of $8.52 billion per share, with estimates ranging from $8.44 billion to $8.61 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Quintiles Transitional Holdings.

Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The company’s revenue was up 68.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.93 EPS.

Q has been the topic of a number of research analyst reports. Royal Bank Of Canada initiated coverage on Quintiles Transitional Holdings in a report on Tuesday, September 19th. They set an “outperform” rating and a $116.00 price target on the stock. KeyCorp restated a “buy” rating and set a $100.00 price target on shares of Quintiles Transitional Holdings in a report on Sunday, September 24th. Argus increased their price target on Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a report on Monday, September 18th. Zacks Investment Research upgraded Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a report on Thursday, July 27th. Finally, BidaskClub upgraded Quintiles Transitional Holdings from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 19th. Eleven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $93.00.

ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Anticipate Quintiles Transitional Holdings Inc. (Q) Will Post Quarterly Sales of $2.02 Billion” was first published by BBNS and is owned by of BBNS. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://baseballnewssource.com/markets/zacks-analysts-anticipate-quintiles-transitional-holdings-inc-q-will-post-quarterly-sales-of-2-02-billion/1700079.html.

Quintiles Transitional Holdings (NYSE:Q) traded up 0.10% during midday trading on Thursday, hitting $95.70. 1,546,728 shares of the stock traded hands. The company has a 50-day moving average of $95.40 and a 200-day moving average of $88.16. The stock has a market cap of $20.72 billion, a PE ratio of 277.39 and a beta of 0.62. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $99.95.

In related news, insider Kevin C. Knightly sold 20,000 shares of the stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total value of $1,805,600.00. Following the completion of the sale, the insider now directly owns 46,826 shares of the company’s stock, valued at approximately $4,227,451.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Kevin C. Knightly sold 19,339 shares of the stock in a transaction on Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the completion of the sale, the insider now directly owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 14,198,382 shares of company stock worth $1,361,834,375. 6.40% of the stock is owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in Q. BlackRock Inc. raised its position in Quintiles Transitional Holdings by 4,217.1% in the 1st quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock valued at $571,660,000 after buying an additional 6,934,290 shares during the last quarter. Janus Henderson Group PLC raised its position in Quintiles Transitional Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after buying an additional 6,512,178 shares during the last quarter. Glenview Capital Management LLC raised its position in Quintiles Transitional Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after buying an additional 2,023,719 shares during the last quarter. Royal Bank of Canada raised its position in Quintiles Transitional Holdings by 103.8% in the 2nd quarter. Royal Bank of Canada now owns 59,335 shares of the medical research company’s stock valued at $5,310,000 after buying an additional 1,601,888 shares during the last quarter. Finally, Discovery Capital Management LLC CT purchased a new stake in Quintiles Transitional Holdings in the 2nd quarter valued at $95,228,000. 93.21% of the stock is owned by institutional investors and hedge funds.

About Quintiles Transitional Holdings

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Get a free copy of the Zacks research report on Quintiles Transitional Holdings (Q)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Red Sox Waste Little Time in Firing John Farrell
Red Sox Waste Little Time in Firing John Farrell


Leave a Reply

 
© 2006-2017 BBNS.